Cargando…
Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence
Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious with fewer adverse events, due to the availability of direct-acting antiviral agents, which target specific steps in the HCV life cycle. Recently, a combination regimen consisting of the HCV nonstructural protein...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132225/ https://www.ncbi.nlm.nih.gov/pubmed/30233138 http://dx.doi.org/10.2147/DDDT.S133697 |